Table 3.

Objective tumor response

	Platinum combination therapy (n = 24) n (%)	Docetaxel monotherapy (n = 61) n (%)	p value*
Complete response	0 (0)	1 (1.6)	0.30
Partial response	4 (16.7)	3 (4.9)
Stable disease	10 (41.7)	31 (50.8)
Progressive disease	9 (37.5)	24 (39.3)
Not evaluable	1 (4.1)	2 (3.3)
Response rate (%)	16.7	6.6	0.09
Disease control ratea (%)	58.3	57.4	0.82

*Fisher’s exact test.

^aComplete response + partial response + stable disease.